Please provide your email address to receive an email when new articles are posted on . In this Healio interview, Sandra D’Angelo, MD, discussed two “interesting” studies for pigmented villonodular ...
SOUTH SAN FRANCISCO, Calif., April 10, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) today announced that it has completed enrollment in the initially planned 30-patient cohort ...
SOUTH SAN FRANCISCO, Calif., June 04, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) announced that a poster featuring initial clinical data from the ongoing Phase 1/2 clinical ...
GDC-0449 in patients with advanced chondrosarcomas: A French Sarcoma Group (FSG)/French and U.S. National Cancer Institutes phase II collaborative study. This is an ASCO Meeting Abstract from the 2012 ...
OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S ...
In fifth grade, Hayden Ruesink was diagnosed with a condition called PVNS, also known as Pigmented Villonodular Synovitis. “Essentially, it’s a non-life-threatening tumor that is in my leg, and it ...
WELLSVILLE — Wellsville firefighter Cody Cole, 41, has recently been diagnosed with Pigmented Villonodular Synovitis (PVNS) in his knee. PVNS is a rare disease that affects between two to eight out of ...